Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Advanced Enzyme Technologies Ltd

NSE: ADVENZYMES · BSE: 540025 · Pharmaceuticals & Biotechnology · 25 announcements

Share price
₹291.15
Market cap
₹3,260 Cr
Revenue (annual)
₹745.8 Cr
Net profit (annual)
₹168.7 Cr
P/E (TTM)
19.6×Sector 50.4×
Promoter holding
43.24%-0.02% QoQ
FII holding
26.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

Time

5 announcements with these filters

15:46 IST BSE
Capital Structure Change

Advanced Enzyme Technologies Capital Structure Change

Advanced Enzyme Technologies Ltd bought back 50,000 equity shares on September 25, 2026. This transaction was executed at an average price of ₹295.80 per share.

Value
₹1.48 Cr
18:05 IST BSE
Capital Structure Change

Advanced Enzyme Technologies Capital Structure Change

Advanced Enzyme Technologies bought back 64,668 shares on September 24, 2026, at an average price of ₹298.0272 per share.

Value
₹1.93 Cr
18:00 IST BSE
Capital Structure Change

Advanced Enzyme Technologies Capital Structure Change

Advanced Enzyme Technologies bought back 63,616 shares at an average price of ₹297.47. The total value of today's buyback transaction is ₹1.89 Crore.

Value
₹1.89 Cr
17:13 IST BSE
Capital Structure Change

Advanced Enzyme Technologies Capital Structure Change

Advanced Enzyme Technologies Ltd repurchased 1,136 equity shares on September 22, 2026, at an average price of ₹295.90. This daily filing is for compliance.

Value
₹0.03 Cr
17:42 IST BSE
Capital Structure Change

Advanced Enzyme Technologies Capital Structure Change

Advanced Enzyme Technologies bought back 50,000 equity shares on September 21, 2026, at an average price of ₹289.49 per share.

Value
₹1.45 Cr